| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.45M | - | |
| CEO | 2.26M | $7.30M | - | |
| Dir | 1.24M | $4.00M | - | |
| CFO | 1.22M | $3.94M | - | |
| Other | 1.10M | $3.54M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Khan Najat | CEO And President | Sell | 28,298 | $3.35 | $94,659.64 | -1.2% | - | - | |
| Jan 6, 2026 | Borgeson Blake69 | Director | Sell | 220,000 | $4.36 | $959,200.00 | -3.2% | -30.8% | - | |
| Jan 5, 2026 | Gibson Christopher70 | Director | Sell | 40,000 | $4.25 | $170,000.00 | -4.1% | -27.9% | - | |
| Dec 29, 2025 | Taylor Ben R | Chief Financial Officer | Sell | 21,383 | $4.18 | $89,380.94 | -2.7% | -31.2% | - | |
| Dec 22, 2025 | Khan Najat | Chief R&D Commercial Officer | Sell | 124,403 | $4.41 | $548,592.35 | -16.9% | -26.6% | - | |
| Dec 19, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $4.50 | $180,000.00 | -4.2% | -20.9% | - | |
| Dec 4, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $4.63 | $185,200.00 | -4.1% | -26.0% | - | |
| Dec 2, 2025 | Borgeson Blake69 | Director | Sell | 220,000 | $4.37 | $961,400.00 | -3.1% | -16.0% | - | |
| Nov 19, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $4.16 | $166,400.00 | -4.2% | -14.1% | - | |
| Nov 4, 2025 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $5.21 | $208,400.00 | -3.9% | -16.4% | - |